Anticoagulation Agents
Factor Xa inhibitor use linked to risk for ILD in patients with atrial fibrillation
In patients with nonvalvular atrial fibrillation receiving oral anticoagulants, factor Xa inhibitors appeared associated with increased risk for interstitial lung disease, according to a study published in JAMA Network Open.
Direct oral anticoagulants safe, effective in patients with valvular AF
Patients with valvular atrial fibrillation who recently began using direct oral anticoagulants had a lower risk for systemic embolism or ischemic stroke and major bleeding compared with new warfarin users, an analysis showed.
Study supports early discharge, ambulatory rivaroxaban in low-risk pulmonary embolism
New data from the HoT-PE trial further support a strategy of early discharge and home oral anticoagulation with rivaroxaban in selected patients with low-risk pulmonary embolism.
Therapeutic anticoagulation ups mortality risk among patients hospitalized with COVID-19
Patients hospitalized with COVID-19 who received high-dose therapeutic anticoagulation appeared to be at increased risk for mortality compared with those on prophylactic anticoagulation, according to a research letter in Thrombosis Research.
Anticoagulation increases risk for death, transplant in patients with ILD
The need for anticoagulation in patients with interstitial lung disease is associated with an increased risk for death and transplant, according to findings published in Chest.
Part of the Healio Network
Endomyocardial Fibrosis
Endomyocardial fibrosis (a.k.a. Davies disease or Loeffler’s endocarditis) occurs from any disorder that elevates the eosinophil count such as parasitic infections.